Rejuvenate Bio

Rejuvenate Bio company information, Employees & Contact Information

Explore related pages

Related company profiles:

Rejuvenate Bio is targeting the core drivers of chronic age-related diseases by unlocking the power of gene expression and epigenetic reprogramming to reverse pre-existing heart disease, metabolic disease, and kidney failure in humans.

Company Details

Employees
15
Founded
-
Phone
858-381-3462
Email
in****@****bio.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Looking for a particular Rejuvenate Bio employee's phone or email?

Rejuvenate Bio Questions

News

Rejuvenate Bio Announces Preclinical Data for Gene Therapy Candidate RJB-0402 for the Treatment of Arrhythmogenic Cardiomyopathy - Diagnostic and Interventional Cardiology

Rejuvenate Bio Announces Preclinical Data for Gene Therapy Candidate RJB-0402 for the Treatment of Arrhythmogenic Cardiomyopathy Diagnostic and Interventional Cardiology

Rejuvenate Bio Announces New Preclinical Research Evaluating Cellular Reprogramming for Age Reversal - Business Wire

Rejuvenate Bio Announces New Preclinical Research Evaluating Cellular Reprogramming for Age Reversal Business Wire

Rejuvenate Bio Finds a Home in Sorrento Valley - San Diego Business Journal

Rejuvenate Bio Finds a Home in Sorrento Valley San Diego Business Journal

Rejuvenate Bio banks $10M to advance gene therapy for aging in humans and dogs - Fierce Biotech

Rejuvenate Bio banks $10M to advance gene therapy for aging in humans and dogs Fierce Biotech

Rejuvenate Bio launches to help dogs live longer, healthier lives - Wyss Institute at Harvard

Rejuvenate Bio launches to help dogs live longer, healthier lives Wyss Institute at Harvard

Rejuvenate Bio is Reversing Age-Related Diseases to Increase Healthspan - BioSpace

Rejuvenate Bio is Reversing Age-Related Diseases to Increase Healthspan BioSpace

Rejuvenate Bio lands $4m grant for gene-therapy research - BioProcess International

Rejuvenate Bio lands $4m grant for gene-therapy research BioProcess International

Phibro Animal Health Corporation and Rejuvenate Bio to develop canine mitral valve disease gene therapy - DVM360

Phibro Animal Health Corporation and Rejuvenate Bio to develop canine mitral valve disease gene therapy DVM360

Rejuvenate Bio CEO highlights ambitious approach of using gene therapy to reverse aging - MedCity News

Rejuvenate Bio CEO highlights ambitious approach of using gene therapy to reverse aging MedCity News

Rejuvenate Bio shows epigenetic reprogramming extends lifespan in normal mice - Longevity.Technology

Rejuvenate Bio shows epigenetic reprogramming extends lifespan in normal mice Longevity.Technology

Rejuvenate Bio Receives $4M in Funding from the California Institute for Regenerative Medicine (CIRM) - Business Wire

Rejuvenate Bio Receives $4M in Funding from the California Institute for Regenerative Medicine (CIRM) Business Wire

A stealthy Harvard startup wants to reverse aging in dogs, and humans could be next - MIT Technology Review

A stealthy Harvard startup wants to reverse aging in dogs, and humans could be next MIT Technology Review

Rejuvenate Bio launches to help dogs live longer, healthier lives - Harvard Office of Technology Development

Rejuvenate Bio launches to help dogs live longer, healthier lives Harvard Office of Technology Development

Gene therapy to fend off aging? Buzzy Harvard startup Rejuvenate Bio says it works in mice - Fierce Biotech

Gene therapy to fend off aging? Buzzy Harvard startup Rejuvenate Bio says it works in mice Fierce Biotech

Rejuvenate Bio Announces Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in the Journal Cellular Reprogramming - Business Wire

Rejuvenate Bio Announces Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in the Journal Cellular Reprogramming Business Wire

Rejuvenate Bio teaches old dogs new tricks - Longevity.Technology

Rejuvenate Bio teaches old dogs new tricks Longevity.Technology

Rejuvenate Bio Announces Data for Gene Therapy RJB-01 in Mitral Valve Disease at 2023 Meeting of the American Society of Gene and Cell Therapy (ASGCT) - Business Wire

Rejuvenate Bio Announces Data for Gene Therapy RJB-01 in Mitral Valve Disease at 2023 Meeting of the American Society of Gene and Cell Therapy (ASGCT) Business Wire

Top Rejuvenate Bio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant